Zuellig, J.A.; Adam, R.; Udry, F.; Tibau, A.; Šeruga, B.; Ocaña, A.; Amir, E.; Templeton, A.J.
The Effect of Staging Intervals on Progression-Free Survival in Registration Studies of Oncologic Drugs: A Meta-Analysis. Cancers 2025, 17, 1359.
https://doi.org/10.3390/cancers17081359
AMA Style
Zuellig JA, Adam R, Udry F, Tibau A, Šeruga B, Ocaña A, Amir E, Templeton AJ.
The Effect of Staging Intervals on Progression-Free Survival in Registration Studies of Oncologic Drugs: A Meta-Analysis. Cancers. 2025; 17(8):1359.
https://doi.org/10.3390/cancers17081359
Chicago/Turabian Style
Zuellig, Jonas A., Roman Adam, Filomena Udry, Ariadna Tibau, Bostjan Šeruga, Alberto Ocaña, Eitan Amir, and Arnoud J. Templeton.
2025. "The Effect of Staging Intervals on Progression-Free Survival in Registration Studies of Oncologic Drugs: A Meta-Analysis" Cancers 17, no. 8: 1359.
https://doi.org/10.3390/cancers17081359
APA Style
Zuellig, J. A., Adam, R., Udry, F., Tibau, A., Šeruga, B., Ocaña, A., Amir, E., & Templeton, A. J.
(2025). The Effect of Staging Intervals on Progression-Free Survival in Registration Studies of Oncologic Drugs: A Meta-Analysis. Cancers, 17(8), 1359.
https://doi.org/10.3390/cancers17081359